- ►ahajournals.org M Juonala, JSA Viikari, T Ronnemaa, L … - … , and vascular biology, 2006 - Am Heart Assoc Methods and Results— Study cohort included 1617 subjects, aged 3 to 18 years at baseline
in 1980. These subjects were reexamined in 2001 at ages 24 to 39 years. In 2001, CRP was
measured from fresh samples, and the subjects underwent carotid IMT study to evaluate ... Cited by 39 - Related articles - All 8 versions
- ►diabetesjournals.org K Krzyzanowska, F Mittermayer, M Wolzt, G … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS— During a median follow-up of 21 (interquartile range 11–27) months, 84 events
occurred in 48 patients. According to multivariate Cox regression analysis, patients with baseline
ADMA or CRP in the highest tertile had a significantly increased hazard ratio for incident ... Cited by 30 - Related articles - BL Direct - All 6 versions
- ►encognitive.com [PDF] A Pradhan - Nutrition Reviews, 2007 - ingentaconnect.com The latter half of the 20 th century has witnessed rapid advances in medicine. Concurrently, secular
trends in lifestyle practices in our increasingly sedentary soci- ety have led to burgeoning rates
of obesity, metabolic syndrome, and type 2 diabetes. The number of Amer- icans with type ... Cited by 26 - Related articles - BL Direct - All 7 versions
L Qi, FB Hu - Current opinion in lipidology, 2007 - journals.lww.com Recent findings: Diets low in glycemic index/load or high in whole grain products have been
associated with decreased concentrations of inflammatory markers and increased adiponectin
levels among diabetic patients. These associations appear to be independent of body ... Cited by 13 - Related articles - BL Direct - All 4 versions
BK Kilhovd, A Juutilainen, S Lehto, T Rönnemaa, PA … - Diabetologia, 2007 - Springer Abstract Aims/hypothesis AGEs, modification products formed by glycation or glycoxidation of
proteins and lipids, have been linked to premature atherosclerosis in patients with diabetes.
We investigated whether increased serum levels of AGEs ... Abbreviations CML N " -( ... Cited by 13 - Related articles - BL Direct - All 4 versions
P Dandona - Mayo Clinic Proceedings, 2008 - mayoclinicproceedings.com Type 2 diabetes mellitus (DM) increases the risk of cardiovascular disease, a major cause of
morbidity and mortality. Central to type 2 DM is insulin resistance, a proinflammatory, hypercoagulable
state that predisposes patients to develop cardiovascular disease and that is associated ... Cited by 11 - Related articles - BL Direct - All 8 versions
H Bays, J McElhattan, BS Bryzinski - Diabetes & Vascular Disease …, 2007 - dvr.sagepub.com Abstract T he efficacy and safety of tesaglitazar (0.5 and 1 mg) and pioglitazone (15, 30 and 45
mg) were compared in a 24-week, randomised, double-blind study in 1,707 patients with type
2 diabetes mellitus. Tesaglitazar 1 mg was non-inferior to pioglitazone 45 mg for change ... Cited by 8 - Related articles - BL Direct - All 6 versions
- ►clinchem.org PM Ridker - Clinical Chemistry, 2008 - Am Assoc Clin Chem Based on more than a decade of evidence, high-sensitivity C-reactive protein (hsCRP) 1 is in
clinical use as an inexpensive adjunct to global cardiovascular risk prediction, as a tool to determine
risk of future diabetes and metabolic syndrome, and as a method for monitoring efficacy of ... Cited by 7 - Related articles - BL Direct - All 3 versions
C Sambanis, K Tziomalos, E Kountana, N Kakavas, I … - Acta Diabetologica, 2008 - Springer Abstract We assessed the effect of the addition of pioglitazone on metabolic control and heart
function of patients with type 2 diabetes already receiving sulfonylurea plus metformin.
Forty-four patients were given 30 mg of pioglitazone for 3 months. Physical examination, ... Cited by 5 - Related articles - BL Direct - All 2 versions
